Therapeutic Peptides Targeting HER-2/ neu and VEGF Signaling Pathways in Breast Cancer

Joan T. Garrett, Sharad Rawale, Stephanie D. Allen, Gary Phillips, Guido Forni, John C. Morris, Pravin T. P. Kaumaya, Novel Engineered Trastuzumab Conformational Epitopes Demonstrate In Vitro and In Vivo Antitumor Properties against HER-2/neu Journal of Immunology. ,vol. 178, pp. 7120- 7131 ,(2007) , 10.4049/JIMMUNOL.178.11.7120

Angelika B. Riemer, Markus Klinger, Stefan Wagner, Astrid Bernhaus, Luca Mazzucchelli, Hubert Pehamberger, Otto Scheiner, Christoph C. Zielinski, Erika Jensen-Jarolim, Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. Journal of Immunology. ,vol. 173, pp. 394- 401 ,(2004) , 10.4049/JIMMUNOL.173.1.394

Brian Fendly, Mien Chie Hung, Robert S. Kerbel, Alicia M. Viloria Petit, Patricia Rockwell, Neil Goldstein, Janusz Rak, Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. American Journal of Pathology. ,vol. 151, pp. 1523- 1530 ,(1997)

N.K. Dakappagari, R. Sundaram, S. Rawale, A. Liner, D.R. Galloway, P.T.P. Kaumaya, Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice. Journal of Peptide Research. ,vol. 65, pp. 189- 199 ,(2008) , 10.1111/J.1399-3011.2005.00212.X

William A. Banks, John S. O'Brien, Deborah A. Otero, Eve M. Taylor, Retro-Inverso Prosaptide Peptides Retain Bioactivity, Are Stable In Vivo, and Are Blood-Brain Barrier Permeable Journal of Pharmacology and Experimental Therapeutics. ,vol. 295, pp. 190- 194 ,(2000)

Naveen K. Dakappagari, Kenneth D. Lute, Sharad Rawale, Joan T. Steele, Stephanie D. Allen, Gary Phillips, R. Todd Reilly, Pravin T. P. Kaumaya, Conformational HER-2/neu B-cell Epitope Peptide Vaccine Designed to Incorporate Two Native Disulfide Bonds Enhances Tumor Cell Binding and Antitumor Activities Journal of Biological Chemistry. ,vol. 280, pp. 54- 63 ,(2005) , 10.1074/JBC.M411020200

Rita Nahta, Francisco J. Esteva, In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells. Cancer Chemotherapy and Pharmacology. ,vol. 53, pp. 186- 190 ,(2004) , 10.1007/S00280-003-0728-3

J. Holash, S. Davis, N. Papadopoulos, S. D. Croll, L. Ho, M. Russell, P. Boland, R. Leidich, D. Hylton, E. Burova, E. Ioffe, T. Huang, C. Radziejewski, K. Bailey, J. P. Fandl, T. Daly, S. J. Wiegand, G. D. Yancopoulos, J. S. Rudge, VEGF-Trap: A VEGF blocker with potent antitumor effects Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 11393- 11398 ,(2002) , 10.1073/PNAS.172398299

Bruce A Keyt, Hung V Nguyen, Lea T Berleau, Carlos M Duarte, Jeanie Park, Helen Chen, Napoleone Ferrara, None, Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors GENERATION OF RECEPTOR-SELECTIVE VEGF VARIANTS BY SITE-DIRECTED MUTAGENESIS Journal of Biological Chemistry. ,vol. 271, pp. 5638- 5646 ,(1996) , 10.1074/JBC.271.10.5638

Hyun-Soo Cho, Karen Mason, Kasra X. Ramyar, Ann Marie Stanley, Sandra B. Gabelli, Dan W. Denney, Daniel J. Leahy, Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab Nature. ,vol. 421, pp. 756- 760 ,(2003) , 10.1038/NATURE01392